Wintest
6721
Showcase
3909
Beauty Kadan Holdings
3041
Cybozu
4776
KODAMA CHEMICAL INDUSTRY
4222
(Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 9.73%30.66B | 0.34%118.34B | 6.94%31.84B | -2.04%28.48B | 1.98%30.09B | -5.60%27.94B | 2.81%117.94B | -3.10%29.77B | 2.08%29.07B | 7.46%29.51B |
Cost of revenue | 5.75%24.6B | 5.66%99.46B | 6.33%26.31B | 4.12%24.05B | 11.02%25.83B | 1.10%23.26B | 8.37%94.13B | 2.97%24.75B | 7.72%23.1B | 12.35%23.27B |
Gross profit | 29.48%6.06B | -20.72%18.88B | 9.98%5.52B | -25.88%4.42B | -31.75%4.26B | -28.99%4.68B | -14.50%23.82B | -24.93%5.02B | -15.11%5.97B | -7.55%6.24B |
Operating expense | -8.68%4.89B | -5.03%21.36B | -1.56%5.38B | -8.09%5.25B | -5.92%5.37B | -4.39%5.36B | 2.92%22.49B | -2.06%5.46B | 3.37%5.71B | 4.54%5.71B |
Operating profit | 272.53%1.17B | -286.59%-2.48B | 132.28%143M | -422.66%-826M | -312.17%-1.12B | -168.52%-677M | -77.90%1.33B | -139.95%-443M | -82.98%256M | -59.00%526M |
Net non-operating interest income (expenses) | -14.55%-252M | 33.08%-1.06B | 62.89%-308M | -8.79%-297M | 0.83%-239M | 10.57%-220M | -49.72%-1.59B | -228.06%-830M | -1.87%-273M | 12.68%-241M |
Non-operating interest income | 273.33%56M | 33.33%48M | 120.00%11M | 11.11%10M | 50.00%12M | 7.14%15M | -14.29%36M | -64.29%5M | 12.50%9M | 100.00%8M |
Non-operating interest expense | 31.06%308M | 5.80%1.11B | 22.69%319M | 8.87%307M | 0.80%251M | -9.62%235M | -4.80%1.05B | -2.62%260M | 2.17%282M | -11.07%249M |
Total other finance cost | ---- | ---- | ---- | ---- | ---- | ---- | --575M | ---- | ---- | ---- |
Net investment income | -8.79%1.51B | 82.57%2.66B | 20,816.67%1.26B | 28.18%-989M | -11.85%744M | -16.83%1.65B | -1.55%1.46B | -99.43%6M | -464.29%-1.38B | 393.57%844M |
Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
Gain(Loss) on derecognition of available-for-sale financial assets | -97.47%10M | 0 | 0 | 395M | 395M | 0 | ||||
Income from associates and other participating interests | 200.00%3M | -64.71%6M | -147.06%-8M | -44.44%5M | 233.33%8M | 133.33%1M | -15.00%17M | 440.00%17M | -47.06%9M | -160.00%-6M |
Special income (charges) | 129.63%48M | -525.82%-4.56B | -6,276.92%-4.02B | 30.15%-234M | 38.82%-145M | 26.70%-162M | 75.83%-728M | 102.64%65M | 2.33%-335M | -21.54%-237M |
Less:Restructuring and mergern&acquisition | ---- | -48.70%79M | -50.00%2M | -98.61%2M | ---- | ---- | 275.61%154M | --4M | --144M | ---- |
Less:Other special charges | -129.63%-48M | 5.40%605M | 304.35%141M | 21.47%232M | -69.70%70M | -26.70%162M | -28.43%574M | -127.82%-69M | -44.31%191M | 18.46%231M |
Less:Write off | ---- | --3.87B | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
Other non-operating income (expenses) | 4,050.00%249M | 0.70%-142M | 118.75%18M | -6.74%-95M | -69.05%-71M | -92.86%6M | -225.00%-143M | -166.67%-96M | -270.83%-89M | 14.29%-42M |
Income before tax | 354.09%2.72B | -855.43%-5.56B | -229.64%-2.91B | -34.72%-2.44B | -195.62%-808M | -76.82%599M | -78.26%736M | -50.85%-884M | -243.46%-1.81B | -10.68%845M |
Income tax | 85.95%794M | -76.82%175M | -244.50%-289M | 527.78%113M | -985.71%-76M | -21.51%427M | -36.39%755M | -42.03%200M | -94.80%18M | -40.00%-7M |
Net income | 1,019.77%1.93B | -31,766.67%-5.74B | -142.61%-2.63B | -39.57%-2.55B | -186.13%-733M | -91.57%172M | -100.82%-18M | -16.22%-1.08B | -299.45%-1.83B | -10.52%851M |
Net income continuous operations | 1,019.77%1.93B | -30,084.21%-5.74B | -142.16%-2.63B | -39.57%-2.55B | -185.92%-732M | -91.57%172M | -100.86%-19M | -16.43%-1.08B | -299.67%-1.83B | -10.41%852M |
Noncontrolling interests | 21.88%-50M | -141.32%-292M | 51.19%-41M | -395.00%-99M | -417.65%-88M | -64M | -384.00%-121M | -366.67%-84M | -185.71%-20M | -466.67%-17M |
Net income attributable to the company | 733.76%1.98B | -5,436.27%-5.44B | -158.66%-2.58B | -35.51%-2.45B | -174.34%-646M | -88.38%237M | -95.41%102M | -9.42%-999M | -296.10%-1.81B | -9.01%869M |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | 733.76%1.98B | -5,436.27%-5.44B | -158.66%-2.58B | -35.51%-2.45B | -174.34%-646M | -88.38%237M | -95.41%102M | -9.42%-999M | -296.10%-1.81B | -9.01%869M |
Gross dividend payment | ||||||||||
Basic earnings per share | 1,082.07%34.28 | -3,116.29%-94.41 | -242.10%-41.12 | -33.84%-43.74 | -190.61%-12.45 | -91.49%2.9 | -90.61%3.13 | 28.79%-12.02 | -323.99%-32.68 | -9.37%13.74 |
Diluted earnings per share | 731.96%16.14 | -3,116.29%-94.41 | -158.66%-44.818 | -33.84%-43.74 | -190.61%-12.45 | -88.14%1.94 | -82.49%3.13 | -2.65%-17.3268 | -323.99%-32.68 | -9.37%13.74 |
Dividend per share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |